TY - JOUR
T1 - Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
AU - Kronzer, Vanessa L.
AU - Yang, Yangyuna
AU - Roul, Punyasha
AU - Crooks, James L.
AU - Crowson, Cynthia S.
AU - Davis, John M.
AU - Sparks, Jeffrey A.
AU - Pierce, Jeffrey R.
AU - O'Dell, Katelyn
AU - Sauer, Brian C.
AU - Cannon, Grant W.
AU - Baker, Joshua F.
AU - Mikuls, Ted R.
AU - England, Bryant R.
N1 - Publisher Copyright:
© 2025 The Author(s). Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
PY - 2025
Y1 - 2025
N2 - Objective: The aim of this study was to determine whether pollutants such as fire smoke–related particulate matter <2.5 μm (PM2.5) are associated with incident rheumatoid arthritis (RA) and RA-associated interstitial lung disease (RA-ILD). Methods: This patient–control study used Veterans Affairs (VA) data from October 1, 2009, to December 31, 2018. We identified patients with incident RA and RA-ILD using validated algorithms, matching each patient to ≤10 controls on age, sex, and VA enrollment year. We obtained pollutants including fire smoke PM2.5, carbon monoxide, nitrogen oxides (NOx), ozone, overall PM2.5, PM10, and sulfur dioxide (SO2) at least one year before the index date. We fit conditional logistic regression models to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs) for incident RA and RA-ILD, adjusted for confounders. Results: We identified 9,701 patients with incident RA (mean age 65 years, 86% male), including 531 patients with RA-ILD (mean age 69 years, 91% male), and 68,852 matched controls. Fire smoke PM2.5 was not associated with RA (aOR 1.07, 95% CI 0.92–1.23) but was associated with RA-ILD (aOR 1.98, 95% CI 1.08–3.62, per 1 μg/m3). Increased levels of NOx were associated with RA (aOR 1.16, 95% CI 1.06–1.27, highest vs lowest quartile). The highest quartiles of ozone (aOR 1.19, 95% CI 1.06–1.34) and PM10 (aOR 1.25, 95% CI 1.10–1.43) were associated with seronegative RA. Carbon monoxide, overall PM2.5, and SO2 were not, or negatively, associated with RA and RA-ILD. Conclusion: Increased fire smoke PM2.5 was associated with RA-ILD, whereas NOx, ozone, and PM10 were associated with RA risk. Thus, air pollution may increase the risk of RA and RA-ILD. (Figure presented.).
AB - Objective: The aim of this study was to determine whether pollutants such as fire smoke–related particulate matter <2.5 μm (PM2.5) are associated with incident rheumatoid arthritis (RA) and RA-associated interstitial lung disease (RA-ILD). Methods: This patient–control study used Veterans Affairs (VA) data from October 1, 2009, to December 31, 2018. We identified patients with incident RA and RA-ILD using validated algorithms, matching each patient to ≤10 controls on age, sex, and VA enrollment year. We obtained pollutants including fire smoke PM2.5, carbon monoxide, nitrogen oxides (NOx), ozone, overall PM2.5, PM10, and sulfur dioxide (SO2) at least one year before the index date. We fit conditional logistic regression models to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs) for incident RA and RA-ILD, adjusted for confounders. Results: We identified 9,701 patients with incident RA (mean age 65 years, 86% male), including 531 patients with RA-ILD (mean age 69 years, 91% male), and 68,852 matched controls. Fire smoke PM2.5 was not associated with RA (aOR 1.07, 95% CI 0.92–1.23) but was associated with RA-ILD (aOR 1.98, 95% CI 1.08–3.62, per 1 μg/m3). Increased levels of NOx were associated with RA (aOR 1.16, 95% CI 1.06–1.27, highest vs lowest quartile). The highest quartiles of ozone (aOR 1.19, 95% CI 1.06–1.34) and PM10 (aOR 1.25, 95% CI 1.10–1.43) were associated with seronegative RA. Carbon monoxide, overall PM2.5, and SO2 were not, or negatively, associated with RA and RA-ILD. Conclusion: Increased fire smoke PM2.5 was associated with RA-ILD, whereas NOx, ozone, and PM10 were associated with RA risk. Thus, air pollution may increase the risk of RA and RA-ILD. (Figure presented.).
UR - http://www.scopus.com/inward/record.url?scp=85216694003&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85216694003&partnerID=8YFLogxK
U2 - 10.1002/art.43113
DO - 10.1002/art.43113
M3 - Article
C2 - 39800945
AN - SCOPUS:85216694003
SN - 2326-5191
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
ER -